首页 > 最新文献

The journal of breast health最新文献

英文 中文
Persistent Left Superior Vena Cava Incidentally Recognized Postoperatively After Venous Port Placement. 术后静脉置入术后偶然发现持续性左上腔静脉。
Pub Date : 2016-10-01 DOI: 10.5152/bs.2016.3250
Dauren Sarsenov, Levent Onat, Vahit Özmen

Persistent left superior vena cava is the most common congenital venous anomaly of the thoracic venous system, occurring in 0.3% to 0.5% of individuals in the general population. It may remain asymptomatic throughout life and be incidentally found in healthy individuals undergoing vascular procedures such as venous access device placements and endovascular cardiac interventions. Here we present a case of persistent left superior vena cava incidentally realized during chemoport insertion in a patient with breast cancer.

持续性左上腔静脉是胸静脉系统最常见的先天性静脉异常,在一般人群中发生率为0.3%至0.5%。它可能终生无症状,并且偶然发现于接受血管手术的健康个体,如静脉通路装置放置和血管内心脏干预。在这里,我们提出了一个病例持续性左上腔静脉偶然发现在化疗插孔插入的乳腺癌患者。
{"title":"Persistent Left Superior Vena Cava Incidentally Recognized Postoperatively After Venous Port Placement.","authors":"Dauren Sarsenov,&nbsp;Levent Onat,&nbsp;Vahit Özmen","doi":"10.5152/bs.2016.3250","DOIUrl":"https://doi.org/10.5152/bs.2016.3250","url":null,"abstract":"<p><p>Persistent left superior vena cava is the most common congenital venous anomaly of the thoracic venous system, occurring in 0.3% to 0.5% of individuals in the general population. It may remain asymptomatic throughout life and be incidentally found in healthy individuals undergoing vascular procedures such as venous access device placements and endovascular cardiac interventions. Here we present a case of persistent left superior vena cava incidentally realized during chemoport insertion in a patient with breast cancer.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351445/pdf/jbh-12-4-177.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34846794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Phyllodes Tumor of the Breast: Analysis of 48 Patients. 乳腺叶状瘤48例分析。
Pub Date : 2016-10-01 DOI: 10.5152/tjbh.2016.3100
Murat Özgür Kılıç, Serdar Gökay Terzioğlu, Betül Bozkurt, Gül Dağlar

Objective: Phyllodes tumor (PT) is a rare biphasic breast neoplasm that accounts for less than 1% of all breast tumors. The aim of this study was to evaluate the clinicopathologic features, diagnostic difficulties, and therapeutic outcomes of patients with PT.

Materials and methods: A total of 48 female patients who underwent surgery for PT were included in the study. Patient characteristics, clinicopathologic features of tumors, diagnostic findings, surgical outcomes, adjuvant therapies, and follow-up findings were retrospectively evaluated.

Results: The mean age of patients was 35 years. Painless breast mass was the most common (85.4%) presenting symptom. Total excision with at least 1 cm macroscopic clear margins was the most frequently performed (87.5%) surgery. Most patients (n=34, 70.8%) had benign PT; however, borderline and malignant tumors were found in 9 (18.8%) and 5 (10.4%) patients, respectively. During the mean follow-up period of approximately 30 months, local and distant recurrence was detected in three (6.3%) patients and one (2.1%) patient, respectively. Patients with malignant PT had larger tumors than those with benign and borderline PTs (p=0.010). No significant difference in other clinical, diagnostic, and pathologic characteristics was found between the groups.

Conclusion: PT can be easily confused with other breast masses such as fibroadenoma due to the non-specific clinical and radiologic findings. Surgical excision with at least 1 cm clear margins is of great importance to reduce the risk of local recurrence. However, recurrence can develop even after appropriate surgery, thus patients should be closely followed up after surgery.

目的:叶状瘤是一种罕见的双相乳腺肿瘤,在所有乳腺肿瘤中所占比例不到1%。本研究的目的是评估PT患者的临床病理特征、诊断困难和治疗结果。材料和方法:共纳入48例接受手术治疗PT的女性患者。回顾性评估患者特征、肿瘤的临床病理特征、诊断结果、手术结果、辅助治疗和随访结果。结果:患者平均年龄35岁。无痛性乳房肿块是最常见的症状(85.4%)。总体切除伴有至少1cm的宏观清晰边缘是最常见的手术(87.5%)。大多数患者(n=34, 70.8%)为良性PT;交界性肿瘤9例(18.8%),恶性肿瘤5例(10.4%)。在平均约30个月的随访期间,分别有3例(6.3%)患者和1例(2.1%)患者出现局部和远处复发。恶性PT患者肿瘤体积大于良性和交界性PT患者(p=0.010)。其他临床、诊断和病理特征在两组间无显著差异。结论:PT易与纤维腺瘤等乳腺肿块混淆,临床及影像学表现不明确。手术切除至少1厘米的清晰边缘对于减少局部复发的风险非常重要。然而,即使在适当的手术后,也可能出现复发,因此患者应在手术后密切随访。
{"title":"Phyllodes Tumor of the Breast: Analysis of 48 Patients.","authors":"Murat Özgür Kılıç, Serdar Gökay Terzioğlu, Betül Bozkurt, Gül Dağlar","doi":"10.5152/tjbh.2016.3100","DOIUrl":"10.5152/tjbh.2016.3100","url":null,"abstract":"<p><strong>Objective: </strong>Phyllodes tumor (PT) is a rare biphasic breast neoplasm that accounts for less than 1% of all breast tumors. The aim of this study was to evaluate the clinicopathologic features, diagnostic difficulties, and therapeutic outcomes of patients with PT.</p><p><strong>Materials and methods: </strong>A total of 48 female patients who underwent surgery for PT were included in the study. Patient characteristics, clinicopathologic features of tumors, diagnostic findings, surgical outcomes, adjuvant therapies, and follow-up findings were retrospectively evaluated.</p><p><strong>Results: </strong>The mean age of patients was 35 years. Painless breast mass was the most common (85.4%) presenting symptom. Total excision with at least 1 cm macroscopic clear margins was the most frequently performed (87.5%) surgery. Most patients (n=34, 70.8%) had benign PT; however, borderline and malignant tumors were found in 9 (18.8%) and 5 (10.4%) patients, respectively. During the mean follow-up period of approximately 30 months, local and distant recurrence was detected in three (6.3%) patients and one (2.1%) patient, respectively. Patients with malignant PT had larger tumors than those with benign and borderline PTs (p=0.010). No significant difference in other clinical, diagnostic, and pathologic characteristics was found between the groups.</p><p><strong>Conclusion: </strong>PT can be easily confused with other breast masses such as fibroadenoma due to the non-specific clinical and radiologic findings. Surgical excision with at least 1 cm clear margins is of great importance to reduce the risk of local recurrence. However, recurrence can develop even after appropriate surgery, thus patients should be closely followed up after surgery.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351441/pdf/jbh-12-4-158.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34846797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer. 乳腺癌患者诊断时18F-FDG摄取水平与组织病理学和免疫组织化学因素的相关性
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.3031
Gamze Uğurluer, Sinan Yavuz, Züleyha Çalıkuşu, Ertuğrul Seyrek, Mustafa Kibar, Meltem Serin, Canan Ersöz, Orhan Demircan

Objective: In this study, we aimed to determine the correlation between pretreatment-staging 18F-FDG total body positron-emission tomography/computed tomography (PET/CT) maximum standardized uptake value (SUVmax) levels and histopathologic and immunohistochemical predictive and prognostic factors in patients with breast cancer.

Materials and methods: One hundred thirty-nine women with breast cancer who were treated between 2009 and 2015 at our hospital and who had pretreatment-staging PET/CT were included in the study. SUVmax levels and histopathologic and immunohistochemical results were compared.

Results: The median age was 48 years (range, 29-79 years). The mean tumor diameter was 33.4 mm (range, 7-120 mm). The histology was invasive ductal carcinoma in 80.6% of the patients. In the univariate analysis, SUVmax levels were significantly higher in patients with invasive ductal carcinoma; in patients with a maximum tumor diameter more than 2 cm; patients who were estrogen, progesterone, and combined hormone receptor-negative, triple-negative patients, and in tumors with higher grades (p<0.05). In HER2-positive patients, SUVmax levels were higher even if it was not statistically significant. There was no correlation between lymph node metastases and pathologic stage. In multivariate analysis, tumor diameter was an independent factor.

Conclusion: SUVmax levels are correlated with known histopathologic and immunohistochemical prognostic factors. PET/CT could be useful in preoperative evaluation of patients with breast cancer to predict biologic characteristics of tumors and prognosis.

目的:在本研究中,我们旨在确定乳腺癌患者治疗前分期18F-FDG全身正电子发射断层扫描/计算机断层扫描(PET/CT)最大标准化摄取值(SUVmax)水平与组织病理学和免疫组织化学预测和预后因素的相关性。材料与方法:本研究纳入2009 - 2015年间在我院接受治疗并进行治疗前分期PET/CT检查的139例乳腺癌患者。比较SUVmax水平及组织病理和免疫组化结果。结果:中位年龄48岁(范围29-79岁)。平均肿瘤直径33.4 mm(范围7 ~ 120 mm)。80.6%的患者组织学为浸润性导管癌。在单因素分析中,浸润性导管癌患者的SUVmax水平显著较高;肿瘤最大直径大于2cm的患者;雌激素、孕激素、联合激素受体阴性、三阴性患者以及肿瘤分级较高的患者(pmax水平较高,即使没有统计学意义)。淋巴结转移与病理分期无相关性。在多因素分析中,肿瘤直径是一个独立的因素。结论:SUVmax水平与已知的组织病理学和免疫组化预后因素相关。PET/CT可用于乳腺癌患者的术前评估,预测肿瘤的生物学特征和预后。
{"title":"Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer.","authors":"Gamze Uğurluer,&nbsp;Sinan Yavuz,&nbsp;Züleyha Çalıkuşu,&nbsp;Ertuğrul Seyrek,&nbsp;Mustafa Kibar,&nbsp;Meltem Serin,&nbsp;Canan Ersöz,&nbsp;Orhan Demircan","doi":"10.5152/tjbh.2016.3031","DOIUrl":"https://doi.org/10.5152/tjbh.2016.3031","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we aimed to determine the correlation between pretreatment-staging 18F-FDG total body positron-emission tomography/computed tomography (PET/CT) maximum standardized uptake value (SUV<sub>max</sub>) levels and histopathologic and immunohistochemical predictive and prognostic factors in patients with breast cancer.</p><p><strong>Materials and methods: </strong>One hundred thirty-nine women with breast cancer who were treated between 2009 and 2015 at our hospital and who had pretreatment-staging PET/CT were included in the study. SUV<sub>max</sub> levels and histopathologic and immunohistochemical results were compared.</p><p><strong>Results: </strong>The median age was 48 years (range, 29-79 years). The mean tumor diameter was 33.4 mm (range, 7-120 mm). The histology was invasive ductal carcinoma in 80.6% of the patients. In the univariate analysis, SUV<sub>max</sub> levels were significantly higher in patients with invasive ductal carcinoma; in patients with a maximum tumor diameter more than 2 cm; patients who were estrogen, progesterone, and combined hormone receptor-negative, triple-negative patients, and in tumors with higher grades (p<0.05). In HER2-positive patients, SUV<sub>max</sub> levels were higher even if it was not statistically significant. There was no correlation between lymph node metastases and pathologic stage. In multivariate analysis, tumor diameter was an independent factor.</p><p><strong>Conclusion: </strong>SUV<sub>max</sub> levels are correlated with known histopathologic and immunohistochemical prognostic factors. PET/CT could be useful in preoperative evaluation of patients with breast cancer to predict biologic characteristics of tumors and prognosis.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351480/pdf/jbh-12-3-112.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34845773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Psychiatric Symptoms and Psychosocial Problems in Patients with Breast Cancer. 乳腺癌患者的精神症状和社会心理问题
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.3041
Filiz İzci, Ahmet Serkan İlgün, Ebru Fındıklı, Vahit Özmen

Cancer is a physical disease and also one of the leading clinical manifestations where psychosocial problems are prevalent. Psychosocial problems that these patients may have in the long run include anxiety, uneasiness, mourning, helplessness, fatigue, impairment of concentration, sleep disorders, mental and cognitive reservation, sexual dysfunction, infertility, psychological distress, and psychiatric disorders. Psychosocial problems have a nature of underpinning the emergence of psychological troubles. The prevalence of psychological disorders in patients with cancer range from 29% to 47%. Psychiatric disorders that are likely to be seen are severe stress disorder, adjustment disorder, depressive disorder, and other neurotic disorders. It is considered by the present author that in the event of breast cancer, potential psychiatric disorders may affect prognosis of the disease, adherance to and success of therapy, social and societal functioning, and survival rate. This paper aims to review the psychiatric symptoms and diseases that may develop in patients with breast cancer, which is one of the most frequent types of a globally common disease; i.e., cancer, as well as the impact of psychiatric symptoms on the treatment of disease.

癌症是一种身体疾病,也是社会心理问题普遍存在的主要临床表现之一。这些患者长期可能出现的社会心理问题包括焦虑、不安、哀悼、无助、疲劳、注意力不集中、睡眠障碍、精神和认知保留、性功能障碍、不孕、心理困扰和精神障碍。社会心理问题具有支撑心理问题出现的本质。癌症患者中心理障碍的患病率从29%到47%不等。可能出现的精神疾病有严重的应激障碍、适应障碍、抑郁症和其他神经性障碍。本作者认为,在乳腺癌的情况下,潜在的精神障碍可能影响疾病的预后、治疗的坚持和成功、社会和社会功能以及生存率。本文旨在综述乳腺癌患者可能出现的精神症状和疾病,乳腺癌是全球最常见的疾病之一;即癌症,以及精神症状对疾病治疗的影响。
{"title":"Psychiatric Symptoms and Psychosocial Problems in Patients with Breast Cancer.","authors":"Filiz İzci, Ahmet Serkan İlgün, Ebru Fındıklı, Vahit Özmen","doi":"10.5152/tjbh.2016.3041","DOIUrl":"10.5152/tjbh.2016.3041","url":null,"abstract":"<p><p>Cancer is a physical disease and also one of the leading clinical manifestations where psychosocial problems are prevalent. Psychosocial problems that these patients may have in the long run include anxiety, uneasiness, mourning, helplessness, fatigue, impairment of concentration, sleep disorders, mental and cognitive reservation, sexual dysfunction, infertility, psychological distress, and psychiatric disorders. Psychosocial problems have a nature of underpinning the emergence of psychological troubles. The prevalence of psychological disorders in patients with cancer range from 29% to 47%. Psychiatric disorders that are likely to be seen are severe stress disorder, adjustment disorder, depressive disorder, and other neurotic disorders. It is considered by the present author that in the event of breast cancer, potential psychiatric disorders may affect prognosis of the disease, adherance to and success of therapy, social and societal functioning, and survival rate. This paper aims to review the psychiatric symptoms and diseases that may develop in patients with breast cancer, which is one of the most frequent types of a globally common disease; i.e., cancer, as well as the impact of psychiatric symptoms on the treatment of disease.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5152/tjbh.2016.3041","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34845771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 53
Periductal Stromal Tumor of the Breast: A Case Report and Review of the Literature. 乳腺导管周围间质瘤1例报告及文献复习。
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.2889
Gökçe Askan, Erkin Arıbal, Gamze Ak, Handan Kaya

We present a woman aged 50 years who underwent a Tru-cut biopsy for a BI-RADS 4 lesion on her right breast and received a histopathology diagnosis of a fibroadenoma. In her one year follow-up, the lesion had progressed and she underwent an excisional biopsy. Her final diagnosis was a periductal stromal tumor. Periductal stromal tumor is an extremely rare and different entity from phylloides tumor, which makes appropriate diagnosis difficult in Tru-cut biopsy and care should be taken. Lesion progression of should require a re-biopsy. Their tendency to recur warrants follow-up. We believe that radiologic, pathologic, and clinical correlation is key in decision-making and diagnosis of these tumors.

我们报告了一名50岁的女性,她在右乳房接受了BI-RADS 4病变的trui -cut活检,并接受了纤维腺瘤的组织病理学诊断。在她一年的随访中,病变进展,她接受了切除活检。她最后的诊断是导管周围间质瘤。导管周围间质瘤是一种极为罕见且不同于叶状瘤的肿瘤,故真切活检难以准确诊断,应引起高度重视。病变进展需要再次活检。他们的复发倾向值得跟进。我们相信放射学、病理学和临床相关是决定和诊断这些肿瘤的关键。
{"title":"Periductal Stromal Tumor of the Breast: A Case Report and Review of the Literature.","authors":"Gökçe Askan,&nbsp;Erkin Arıbal,&nbsp;Gamze Ak,&nbsp;Handan Kaya","doi":"10.5152/tjbh.2016.2889","DOIUrl":"https://doi.org/10.5152/tjbh.2016.2889","url":null,"abstract":"<p><p>We present a woman aged 50 years who underwent a Tru-cut biopsy for a BI-RADS 4 lesion on her right breast and received a histopathology diagnosis of a fibroadenoma. In her one year follow-up, the lesion had progressed and she underwent an excisional biopsy. Her final diagnosis was a periductal stromal tumor. Periductal stromal tumor is an extremely rare and different entity from phylloides tumor, which makes appropriate diagnosis difficult in Tru-cut biopsy and care should be taken. Lesion progression of should require a re-biopsy. Their tendency to recur warrants follow-up. We believe that radiologic, pathologic, and clinical correlation is key in decision-making and diagnosis of these tumors.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351483/pdf/jbh-12-3-133.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34845770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Transcatheter Arterial Embolization for Controlling Severe Bleeding From Recurrent Locally-Advanced Breast Cancer. 经导管动脉栓塞治疗局部晚期复发性乳腺癌大出血。
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.2952
Şefika Aksoy, Bülent Akçe, Özgür Kılıçkesmez, Rıza Umar Gürsü, Mehmet Semih Çakır, Mehmet Ali Nazlı, Acar Aren
One of the rare but most challenging issues in the management of the locally-advanced breast cancer (LABC) is life-threatening bleeding from the fungating and/or ulcerating focus (foci) of these tumors. Breast surgeons may need the assistance of interventional radiologists to solve this urgent condition if surgery cannot provide sufficient benefit. Herein, we report a case of recurrent locally-advanced breast cancer that presented with sudden severe bleeding, which was stopped by an interventional radiologist via transcatheter arterial embolization (TAE). In addition, we evaluate the role of interventional radiology in patients with breast cancer who present with bleeding from the breast by reviewing the relevant literature.
在局部晚期乳腺癌(LABC)的治疗中,罕见但最具挑战性的问题之一是这些肿瘤的真菌和/或溃疡灶(foci)引起的危及生命的出血。如果手术不能提供足够的好处,乳房外科医生可能需要介入放射科医生的协助来解决这种紧急情况。在此,我们报告一例复发的局部晚期乳腺癌,表现为突然严重出血,经介入放射科医生经导管动脉栓塞(TAE)停止。此外,我们通过回顾相关文献来评估介入放射学在出现乳房出血的乳腺癌患者中的作用。
{"title":"Transcatheter Arterial Embolization for Controlling Severe Bleeding From Recurrent Locally-Advanced Breast Cancer.","authors":"Şefika Aksoy,&nbsp;Bülent Akçe,&nbsp;Özgür Kılıçkesmez,&nbsp;Rıza Umar Gürsü,&nbsp;Mehmet Semih Çakır,&nbsp;Mehmet Ali Nazlı,&nbsp;Acar Aren","doi":"10.5152/tjbh.2016.2952","DOIUrl":"https://doi.org/10.5152/tjbh.2016.2952","url":null,"abstract":"One of the rare but most challenging issues in the management of the locally-advanced breast cancer (LABC) is life-threatening bleeding from the fungating and/or ulcerating focus (foci) of these tumors. Breast surgeons may need the assistance of interventional radiologists to solve this urgent condition if surgery cannot provide sufficient benefit. Herein, we report a case of recurrent locally-advanced breast cancer that presented with sudden severe bleeding, which was stopped by an interventional radiologist via transcatheter arterial embolization (TAE). In addition, we evaluate the role of interventional radiology in patients with breast cancer who present with bleeding from the breast by reviewing the relevant literature.","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351484/pdf/jbh-12-3-137.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34845772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Factors that Affect Drain Indwelling Time after Breast Cancer Surgery. 影响乳腺癌术后引流管留置时间的因素。
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.3070
Ömer Uslukaya, Ahmet Türkoğlu, Metehan Gümüş, Zübeyir Bozdağ, Ahmet Yılmaz, Hatice Gümüş, Şeyhmus Kaya, Mesut Gül

Objective: The most common procedure to prevent seroma formation, a common complication after breast and axillary surgery, is to use prophylactic surgical drains. Ongoing discussions continue regarding the ideal time for removing drains after surgical procedures. In this study, we aimed to investigate factors that affect drain indwelling time (DIT).

Materials and methods: From 2014 to 2015, a total of 91 consecutive patients with breast cancer were included in the study. The demographic characteristics of the patients, treatment methods, histopathologic features of the tumor, size of removed breast tissue (BS), tumor size (TS), number of totally removed lymph nodes (TLN), and metastatic lymph nodes (MLN), whether they had neoadjuvant chemotherapy, and the DIT were retrospectively recorded from the hospital database.

Results: The mean age of the patients was 48.9 years, and the mean DIT was 4.8 days. The mean size of breast removed was 17.3 cm and tumor size was 4.7 cm, and the mean number of metastatic lymph nodes was 3.3, and mean total number of lymph nodes was 14.1. Patients who had neoadjuvant chemotherahpy had longer DIT. There was a positive correlation between the BS, TS, TLN, MLN, length of hospital stay, and DIT. Linear regresion analysis revealed that the BS, TLN, and history of neoadjuvant chemotherahpy were independent risk factors for DIT.

Conclusion: DIT primarily depends on BS, TLN, and history of neoadjuvant chemotherahpy. A policy for the management of removing drains to prevent seroma formation should thus be individualized.

目的:预防乳腺和腋窝手术后常见的并发症——血肿形成的最常见方法是预防性手术引流。关于外科手术后清除引流管的理想时间的讨论仍在继续。本研究旨在探讨影响引流管留置时间(DIT)的因素。材料与方法:2014 - 2015年共纳入91例连续乳腺癌患者。回顾性记录患者的人口学特征、治疗方法、肿瘤的组织病理学特征、乳腺切除组织大小(BS)、肿瘤大小(TS)、完全切除淋巴结数(TLN)、转移性淋巴结数(MLN)、是否接受新辅助化疗、DIT。结果:患者平均年龄48.9岁,平均DIT为4.8天。切除乳腺平均大小17.3 cm,肿瘤大小4.7 cm,平均转移淋巴结数3.3个,平均淋巴结总数14.1个。接受新辅助化疗的患者DIT更长。BS、TS、TLN、MLN、住院时间与DIT呈正相关。线性回归分析显示,BS、TLN和新辅助化疗史是DIT的独立危险因素。结论:DIT主要取决于BS、TLN和新辅助化疗史。因此,清除引流管以防止血肿形成的管理策略应个体化。
{"title":"Factors that Affect Drain Indwelling Time after Breast Cancer Surgery.","authors":"Ömer Uslukaya,&nbsp;Ahmet Türkoğlu,&nbsp;Metehan Gümüş,&nbsp;Zübeyir Bozdağ,&nbsp;Ahmet Yılmaz,&nbsp;Hatice Gümüş,&nbsp;Şeyhmus Kaya,&nbsp;Mesut Gül","doi":"10.5152/tjbh.2016.3070","DOIUrl":"https://doi.org/10.5152/tjbh.2016.3070","url":null,"abstract":"<p><strong>Objective: </strong>The most common procedure to prevent seroma formation, a common complication after breast and axillary surgery, is to use prophylactic surgical drains. Ongoing discussions continue regarding the ideal time for removing drains after surgical procedures. In this study, we aimed to investigate factors that affect drain indwelling time (DIT).</p><p><strong>Materials and methods: </strong>From 2014 to 2015, a total of 91 consecutive patients with breast cancer were included in the study. The demographic characteristics of the patients, treatment methods, histopathologic features of the tumor, size of removed breast tissue (BS), tumor size (TS), number of totally removed lymph nodes (TLN), and metastatic lymph nodes (MLN), whether they had neoadjuvant chemotherapy, and the DIT were retrospectively recorded from the hospital database.</p><p><strong>Results: </strong>The mean age of the patients was 48.9 years, and the mean DIT was 4.8 days. The mean size of breast removed was 17.3 cm and tumor size was 4.7 cm, and the mean number of metastatic lymph nodes was 3.3, and mean total number of lymph nodes was 14.1. Patients who had neoadjuvant chemotherahpy had longer DIT. There was a positive correlation between the BS, TS, TLN, MLN, length of hospital stay, and DIT. Linear regresion analysis revealed that the BS, TLN, and history of neoadjuvant chemotherahpy were independent risk factors for DIT.</p><p><strong>Conclusion: </strong>DIT primarily depends on BS, TLN, and history of neoadjuvant chemotherahpy. A policy for the management of removing drains to prevent seroma formation should thus be individualized.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351478/pdf/jbh-12-3-102.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34845854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey. 早期乳腺癌Oncotype DX复发评分与经典危险因素的相关性:土耳其一项前瞻性多中心研究的结果
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.2874
Vahit Özmen, Ajlan Atasoy, Erhan Gökmen, Mustafa Özdoğan, Nilufer Güler, Cihan Uras, Engin Ok, Orhan Demircan, Abdurrahman Işıkkdoğan, Neslihan Cabioğlu, Fatma Şen, Pınar Saip

Objective: Breast cancer is the most common malignancy among Turkish women and the rate of early stage disease is increasing. The Oncotype DX 21-gene assay is predictive of distant recurrence in ER-positive, HER2-negative early breast cancer. We aimed to evaluate the correlations between Recurrence Score (RS) and routine risk factors.

Materials and methods: Ten academic centers across Turkey participated in this prospective trial. Consecutive patients with breast cancer who had pT1-3, pN0-N1mic, ER-positive, and HER2-negative tumors were identified at tumor conferences. Both pre- and post-RS treatment decisions and physician perceptions were recorded on questionnaire forms. Correlations between RS and classic risk factors were evaluated using univariate and multivariate analyses.

Results: Ten centers enrolled a total of 165 patients. The median tumor size was 2 cm. Of the 165 patients, 57% had low RS, 35% had intermediate RS, and 8% had high RS, respectively. Multivariate analysis indicated that progesterone receptor (PR) and Ki67 scores were significantly related to RS.

Conclusion: Oncotype DX Recurrence Score does not seem to have a significant correlation with the majority of classic risk factors, but it may have a correlation with PR score and Ki67 score.

目的:乳腺癌是土耳其妇女中最常见的恶性肿瘤,早期发病率呈上升趋势。Oncotype DX 21基因检测可预测er阳性、her2阴性早期乳腺癌远处复发。我们的目的是评估复发评分(RS)与常规危险因素之间的相关性。材料和方法:土耳其的十个学术中心参与了这项前瞻性试验。在肿瘤会议上发现了pT1-3、pN0-N1mic、er阳性和her2阴性肿瘤的连续乳腺癌患者。rs前后的治疗决定和医生的看法都记录在问卷表格上。采用单因素和多因素分析评估RS与经典危险因素之间的相关性。结果:10个中心共纳入165例患者。中位肿瘤大小为2cm。165例患者中,57%为低RS, 35%为中等RS, 8%为高RS。多因素分析显示,孕激素受体(PR)和Ki67评分与rs有显著相关性。结论:Oncotype DX复发评分与大多数经典危险因素似乎没有显著相关性,但可能与PR评分和Ki67评分有相关性。
{"title":"Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey.","authors":"Vahit Özmen,&nbsp;Ajlan Atasoy,&nbsp;Erhan Gökmen,&nbsp;Mustafa Özdoğan,&nbsp;Nilufer Güler,&nbsp;Cihan Uras,&nbsp;Engin Ok,&nbsp;Orhan Demircan,&nbsp;Abdurrahman Işıkkdoğan,&nbsp;Neslihan Cabioğlu,&nbsp;Fatma Şen,&nbsp;Pınar Saip","doi":"10.5152/tjbh.2016.2874","DOIUrl":"https://doi.org/10.5152/tjbh.2016.2874","url":null,"abstract":"<p><strong>Objective: </strong>Breast cancer is the most common malignancy among Turkish women and the rate of early stage disease is increasing. The Oncotype DX 21-gene assay is predictive of distant recurrence in ER-positive, HER2-negative early breast cancer. We aimed to evaluate the correlations between Recurrence Score (RS) and routine risk factors.</p><p><strong>Materials and methods: </strong>Ten academic centers across Turkey participated in this prospective trial. Consecutive patients with breast cancer who had pT1-3, pN0-N1mic, ER-positive, and HER2-negative tumors were identified at tumor conferences. Both pre- and post-RS treatment decisions and physician perceptions were recorded on questionnaire forms. Correlations between RS and classic risk factors were evaluated using univariate and multivariate analyses.</p><p><strong>Results: </strong>Ten centers enrolled a total of 165 patients. The median tumor size was 2 cm. Of the 165 patients, 57% had low RS, 35% had intermediate RS, and 8% had high RS, respectively. Multivariate analysis indicated that progesterone receptor (PR) and Ki67 scores were significantly related to RS.</p><p><strong>Conclusion: </strong>Oncotype DX Recurrence Score does not seem to have a significant correlation with the majority of classic risk factors, but it may have a correlation with PR score and Ki67 score.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351479/pdf/jbh-12-3-107.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34845855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Diagnostic Value of Diffusion-weighted Imaging and Apparent Diffusion Coefficient Values in the Differentiation of Breast Lesions, Histpathologic Subgroups and Correlatıon with Prognostıc Factors using 3.0 Tesla MR. 3.0 Tesla MR弥散加权成像及表观弥散系数值对乳腺病变、组织病理亚组及Correlatıon与Prognostıc因子鉴别的诊断价值
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.2897
Yasin Akın, M Ümit Uğurlu, Handan Kaya, Erkin Arıbal

Objective: The aim of this study was to evaluate the effect of the apparent diffusion coefficient (ADC) and diffusion-weighted imaging in differentiating benign from malignant breast lesions, histopathologic subtypes of breast tumors, and to find a correlation with prognostic factors using 3T MR.

Materials and methods: A total of 165 patients aged between 16 and 78 years with 181 histopathologically-verifed breast lesions were enrolled in this study. A 3T MR system and bilateral phased array breast coil was used. Diffusion-weighted imaging was performed with spin echo "echo planar" with "b" values: 50, 400, and 800 seconds/mm2. ADC values were calculated for normal fibroglandular tissue and breast lesions. ADC values of independent groups were compared using Student's t-test. ROC analysis was used to find a threshold ADC value in the differentiation of lesions.

Results: The mean ADC values were 1.35±0.16 × 10-3 mm2/s for normal fibroglandular tissue, 1.41±0.24 × 10-3 mm2/s for benign breast lesions and 0.83±0.19 × 10-3 mm2/s for malignant breast lesions. The AUC with ROC analysis was 0.945 and the threshold for ADC was 1.08 × 10-3 mm2/s with a sensitivity and specificity of 92% and 92%, respectively. The threshold value for ADC ratio was 0.9 with 96% sensitivity and 89% specificity. The mean ADC of malignant breast lesions was statistically lower for benign lesions (p<0.01). We found no correlation between the mean ADC values and ER-PR receptor, Her2, and Ki-67 values.

Conclusion: Diffusion-weighted imaging has high diagnostic value with high sensitivity and specificity in differentiating malignant and benign breast lesions.

目的:本研究旨在评价表观弥散系数(ADC)和弥散加权成像在3T mr鉴别乳腺良恶性病变、乳腺肿瘤组织病理亚型中的作用,并探讨其与预后因素的相关性。材料和方法:共纳入165例年龄在16 ~ 78岁之间、经组织病理证实的乳腺病变181例的患者。采用3T磁共振系统和双侧相控阵乳房线圈。采用自旋回波“回波平面”进行弥散加权成像,“b”值分别为50、400和800秒/mm2。计算正常纤维腺组织和乳腺病变的ADC值。独立组ADC值比较采用Student's t检验。采用ROC分析寻找病变分化的阈值ADC值。结果:正常纤维腺组织ADC平均值为1.35±0.16 × 10-3 mm2/s,乳腺良性病变ADC平均值为1.41±0.24 × 10-3 mm2/s,乳腺恶性病变ADC平均值为0.83±0.19 × 10-3 mm2/s。ROC分析的AUC为0.945,ADC的阈值为1.08 × 10-3 mm2/s,敏感性为92%,特异性为92%。ADC比值的阈值为0.9,敏感性96%,特异性89%。乳腺恶性病变的平均ADC明显低于良性病变(p结论:弥散加权成像对乳腺良恶性病变鉴别具有较高的敏感性和特异性,具有较高的诊断价值。
{"title":"Diagnostic Value of Diffusion-weighted Imaging and Apparent Diffusion Coefficient Values in the Differentiation of Breast Lesions, Histpathologic Subgroups and Correlatıon with Prognostıc Factors using 3.0 Tesla MR.","authors":"Yasin Akın,&nbsp;M Ümit Uğurlu,&nbsp;Handan Kaya,&nbsp;Erkin Arıbal","doi":"10.5152/tjbh.2016.2897","DOIUrl":"https://doi.org/10.5152/tjbh.2016.2897","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to evaluate the effect of the apparent diffusion coefficient (ADC) and diffusion-weighted imaging in differentiating benign from malignant breast lesions, histopathologic subtypes of breast tumors, and to find a correlation with prognostic factors using 3T MR.</p><p><strong>Materials and methods: </strong>A total of 165 patients aged between 16 and 78 years with 181 histopathologically-verifed breast lesions were enrolled in this study. A 3T MR system and bilateral phased array breast coil was used. Diffusion-weighted imaging was performed with spin echo \"echo planar\" with \"b\" values: 50, 400, and 800 seconds/mm<sup>2</sup>. ADC values were calculated for normal fibroglandular tissue and breast lesions. ADC values of independent groups were compared using Student's t-test. ROC analysis was used to find a threshold ADC value in the differentiation of lesions.</p><p><strong>Results: </strong>The mean ADC values were 1.35±0.16 × 10<sup>-3</sup> mm<sup>2</sup>/s for normal fibroglandular tissue, 1.41±0.24 × 10<sup>-3</sup> mm<sup>2</sup>/s for benign breast lesions and 0.83±0.19 × 10<sup>-3</sup> mm<sup>2</sup>/s for malignant breast lesions. The AUC with ROC analysis was 0.945 and the threshold for ADC was 1.08 × 10<sup>-3</sup> mm<sup>2</sup>/s with a sensitivity and specificity of 92% and 92%, respectively. The threshold value for ADC ratio was 0.9 with 96% sensitivity and 89% specificity. The mean ADC of malignant breast lesions was statistically lower for benign lesions (p<0.01). We found no correlation between the mean ADC values and ER-PR receptor, Her2, and Ki-67 values.</p><p><strong>Conclusion: </strong>Diffusion-weighted imaging has high diagnostic value with high sensitivity and specificity in differentiating malignant and benign breast lesions.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351482/pdf/jbh-12-3-123.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34845774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Subcutaneous Oleomas Following Sunflower Oil Injection: A Novel Case and Review of Literature. 葵花籽油注射后皮下油瘤:一例新病例及文献回顾。
Pub Date : 2016-07-01 DOI: 10.5152/tjbh.2016.3115
Özgür Sarıca, Arda Kayhan, Hüseyin Cengiz Demirkürek, Ayşenur Akyıldız İğdem

Liquid foreign material injection has been used as an early medical intervention since the end of nineteenth century for the augmentation of body shape. Nowadays, these types of procedures have been abandoned by health professionals due to late onset of serious complications. However, it is still misused by some subcultures such as bodybuilders, passive homosexuals, transsexuals, and patients with mental illness. This article discusses a male patient who injected himself with a large amount of sunflower oil, which became complicated by an inflammatory response-abscess formation and sclerosing lipogranuloma of breasts. The radiologic and pathologic signs of this entity are discussed with a review of the relevant literature. Lack of suspicion of this entity may cause a great delay in establishment of definitive diagnosis, giving rise to prominent morbidity and mortality. It is necessary to know the diagnosis and treatment of this phenomenon because illegal substances that cause factitial panniculitis are widely available on websites and threaten thousands of people, which is anecdotally referred in medical literature. Chronic or recurrent lesions of a bizarre or atypical morphology should alert the physician to this artificial phenomenon. Radiologic findings are most important criteria for diagnosis because self-injection is denied by the patient.

自19世纪末以来,液体异物注射已被用作早期的医学干预措施,以增强体型。如今,这些类型的程序已被卫生专业人员放弃,因为严重的并发症晚发。然而,它仍然被一些亚文化误用,如健美运动员、被动同性恋者、变性者和精神病患者。这篇文章讨论了一个男性病人注射了大量的葵花籽油,这变得复杂的炎症反应-脓肿形成和硬化性脂肪肉芽肿的乳房。该实体的放射学和病理征象进行了讨论,并回顾了相关文献。对这一实体缺乏怀疑可能会导致确定明确诊断的严重延误,从而引起显著的发病率和死亡率。了解这一现象的诊断和治疗是必要的,因为引起假性全身性炎的非法物质在网站上广泛存在,威胁着成千上万的人,这在医学文献中是轶事性的。慢性或复发病变的奇异或非典型的形态应提醒医生这一人为现象。由于患者拒绝自我注射,放射学表现是诊断的最重要标准。
{"title":"Subcutaneous Oleomas Following Sunflower Oil Injection: A Novel Case and Review of Literature.","authors":"Özgür Sarıca,&nbsp;Arda Kayhan,&nbsp;Hüseyin Cengiz Demirkürek,&nbsp;Ayşenur Akyıldız İğdem","doi":"10.5152/tjbh.2016.3115","DOIUrl":"https://doi.org/10.5152/tjbh.2016.3115","url":null,"abstract":"<p><p>Liquid foreign material injection has been used as an early medical intervention since the end of nineteenth century for the augmentation of body shape. Nowadays, these types of procedures have been abandoned by health professionals due to late onset of serious complications. However, it is still misused by some subcultures such as bodybuilders, passive homosexuals, transsexuals, and patients with mental illness. This article discusses a male patient who injected himself with a large amount of sunflower oil, which became complicated by an inflammatory response-abscess formation and sclerosing lipogranuloma of breasts. The radiologic and pathologic signs of this entity are discussed with a review of the relevant literature. Lack of suspicion of this entity may cause a great delay in establishment of definitive diagnosis, giving rise to prominent morbidity and mortality. It is necessary to know the diagnosis and treatment of this phenomenon because illegal substances that cause factitial panniculitis are widely available on websites and threaten thousands of people, which is anecdotally referred in medical literature. Chronic or recurrent lesions of a bizarre or atypical morphology should alert the physician to this artificial phenomenon. Radiologic findings are most important criteria for diagnosis because self-injection is denied by the patient.</p>","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351485/pdf/jbh-12-3-141.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34846791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
期刊
The journal of breast health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1